CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 186 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $657,000 | +26.8% | 55,260 | +25.2% | 0.18% | -29.0% |
| Q1 2019 | $518,000 | -29.6% | 44,128 | -19.9% | 0.25% | -41.6% |
| Q4 2018 | $736,000 | -20.5% | 55,110 | -16.5% | 0.42% | -4.9% |
| Q3 2018 | $926,000 | -38.0% | 66,021 | -30.5% | 0.45% | -34.2% |
| Q2 2018 | $1,493,000 | – | 95,000 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
| TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
| S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
| Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
| AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
| Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
| Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
| AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
| Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
| Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |